Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Laennec in Chronic Fatigue Syndrome
NCT01742013Phase 3Completed
- Start
- Jan 2013
- Primary completion
- Aug 2013
- Modality
- Device-based Delivery
- Countries
- 1
01
Overview
A Phase 3 trial of LAENNEC in myalgic encephalomyelitis chronic fatigue syndrome (ME/CFS), myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS). Started Jan 2013; status: completed.
02
Drugs
LAENNEC
03
Conditions
myalgic encephalomyelitis chronic fatigue syndrome (ME/CFS)myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS)
Beyond the preview
Go deeper on NCT01742013.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01742013.